Cargando…

Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry

Neurofibromatosis type 1 (NF1) is a rare genetic disorder, characterized by the development of benign and malignant nerve tumors. Although all individuals with NF1 harbor genetic alterations in the same gene, the clinical manifestations of NF1 are extremely heterogeneous even among individuals who c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabata, Mika M., Li, Shufeng, Knight, Pamela, Bakker, Annette, Sarin, Kavita Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455126/
https://www.ncbi.nlm.nih.gov/pubmed/32814709
http://dx.doi.org/10.1172/jci.insight.136262
_version_ 1783575568458973184
author Tabata, Mika M.
Li, Shufeng
Knight, Pamela
Bakker, Annette
Sarin, Kavita Y.
author_facet Tabata, Mika M.
Li, Shufeng
Knight, Pamela
Bakker, Annette
Sarin, Kavita Y.
author_sort Tabata, Mika M.
collection PubMed
description Neurofibromatosis type 1 (NF1) is a rare genetic disorder, characterized by the development of benign and malignant nerve tumors. Although all individuals with NF1 harbor genetic alterations in the same gene, the clinical manifestations of NF1 are extremely heterogeneous even among individuals who carry identical genetic defects. In order to deepen the understanding of phenotypic manifestations in NF1, we comprehensively characterized the prevalence of 18 phenotypic traits in 2051 adults with NF1 from the Children’s Tumor Foundation’s NF1 registry. We further investigated the coassociation of traits and found positive correlations between spinal neurofibromas and pain, spinal neurofibromas and scoliosis, spinal neurofibromas and optic gliomas, and optic gliomas and sphenoid wing dysplasia. Furthermore, with increasing numbers of cutaneous neurofibromas, the odds ratio of malignant peripheral nerve sheath tumor increased. Phenotypic clustering revealed 6 phenotypic patient cluster subtypes: mild, freckling predominant, neurofibroma predominant, skeletal predominant, late-onset neural severe, and early-onset neural severe, highlighting potential phenotypic subtypes within NF1. Together, our results support potential shared molecular pathogenesis for certain clinical manifestations and illustrate the utility of disease registries for understanding rare diseases.
format Online
Article
Text
id pubmed-7455126
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-74551262020-09-01 Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry Tabata, Mika M. Li, Shufeng Knight, Pamela Bakker, Annette Sarin, Kavita Y. JCI Insight Research Article Neurofibromatosis type 1 (NF1) is a rare genetic disorder, characterized by the development of benign and malignant nerve tumors. Although all individuals with NF1 harbor genetic alterations in the same gene, the clinical manifestations of NF1 are extremely heterogeneous even among individuals who carry identical genetic defects. In order to deepen the understanding of phenotypic manifestations in NF1, we comprehensively characterized the prevalence of 18 phenotypic traits in 2051 adults with NF1 from the Children’s Tumor Foundation’s NF1 registry. We further investigated the coassociation of traits and found positive correlations between spinal neurofibromas and pain, spinal neurofibromas and scoliosis, spinal neurofibromas and optic gliomas, and optic gliomas and sphenoid wing dysplasia. Furthermore, with increasing numbers of cutaneous neurofibromas, the odds ratio of malignant peripheral nerve sheath tumor increased. Phenotypic clustering revealed 6 phenotypic patient cluster subtypes: mild, freckling predominant, neurofibroma predominant, skeletal predominant, late-onset neural severe, and early-onset neural severe, highlighting potential phenotypic subtypes within NF1. Together, our results support potential shared molecular pathogenesis for certain clinical manifestations and illustrate the utility of disease registries for understanding rare diseases. American Society for Clinical Investigation 2020-08-20 /pmc/articles/PMC7455126/ /pubmed/32814709 http://dx.doi.org/10.1172/jci.insight.136262 Text en © 2020 Tabata et al. http://creativecommons.org/licenses/by/4.0/ This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Tabata, Mika M.
Li, Shufeng
Knight, Pamela
Bakker, Annette
Sarin, Kavita Y.
Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
title Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
title_full Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
title_fullStr Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
title_full_unstemmed Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
title_short Phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
title_sort phenotypic heterogeneity of neurofibromatosis type 1 in a large international registry
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455126/
https://www.ncbi.nlm.nih.gov/pubmed/32814709
http://dx.doi.org/10.1172/jci.insight.136262
work_keys_str_mv AT tabatamikam phenotypicheterogeneityofneurofibromatosistype1inalargeinternationalregistry
AT lishufeng phenotypicheterogeneityofneurofibromatosistype1inalargeinternationalregistry
AT knightpamela phenotypicheterogeneityofneurofibromatosistype1inalargeinternationalregistry
AT bakkerannette phenotypicheterogeneityofneurofibromatosistype1inalargeinternationalregistry
AT sarinkavitay phenotypicheterogeneityofneurofibromatosistype1inalargeinternationalregistry